BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10559626)

  • 1. Management of symptomatic BPH in France: who is treated and how?
    Lukacs B
    Eur Urol; 1999; 36 Suppl 3():14-20. PubMed ID: 10559626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of symptomatic BPH in the UK: who is treated and how?
    McNicholas TA
    Eur Urol; 1999; 36 Suppl 3():33-9. PubMed ID: 10559629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of symptomatic BPH in the US: who is treated and how?
    Bruskewitz R
    Eur Urol; 1999; 36 Suppl 3():7-13. PubMed ID: 10559625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of symptomatic BPH in Italy: who is treated and how?
    Tubaro A; Montanari E
    Eur Urol; 1999; 36 Suppl 3():28-32. PubMed ID: 10559628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of the BPH syndrome in Germany: who is treated and how?
    Berges RR; Pientka L
    Eur Urol; 1999; 36 Suppl 3():21-7. PubMed ID: 10559627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower urinary tract symptoms suggestive of benign prostatic obstruction: what are the current practice patterns?
    McNicholas TA
    Eur Urol; 2001; 39 Suppl 3():26-30. PubMed ID: 11275739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study.
    Lukacs B; Cornu JN; Aout M; Tessier N; Hodée C; Haab F; Cussenot O; Merlière Y; Moysan V; Vicaut E
    Eur Urol; 2013 Sep; 64(3):493-501. PubMed ID: 23465519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Do urologists apply benign prostatic hyperplasia clinical practice guidelines? Survey on the complementary investigation request modalities in France].
    de la Taille A; Desgrandchamps F; Saussine C; Lukacs B; Haillot O
    Prog Urol; 2004 Jun; 14(3):320-5. PubMed ID: 15373173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How are lower urinary tract symptoms managed in real life practice? The French experience.
    Vallancien G
    Eur Urol; 2000; 38 Suppl 1():54-9. PubMed ID: 11111209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
    Kaplan SA; Olsson CA; Te AE
    J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do symptoms indicative of BPH progress in real life practice? The UK experience.
    Clifford GM; Logie J; Farmer RD
    Eur Urol; 2000; 38 Suppl 1():48-53. PubMed ID: 11111208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
    Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
    J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [National trend of management of benign prostatic hyperplasia in Japan during 1990s: analysis of national health statistics].
    Terai A; Kakehi Y; Terachi T; Ogawa O
    Hinyokika Kiyo; 2000 Aug; 46(8):537-44. PubMed ID: 11019372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.
    Speakman M; Kirby R; Doyle S; Ioannou C
    BJU Int; 2015 Apr; 115(4):508-19. PubMed ID: 24656222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening of clinical benign prostatic hypertrophy in general practice: survey of 18,540 men].
    Flam T; Montauban V
    Prog Urol; 2003 Jun; 13(3):416-24. PubMed ID: 12940193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of lower urinary tract symptoms of elderly men in Austria.
    Madersbacher S; Haidinger G; Struhal G;
    Eur Urol; 2001 Feb; 39(2):145-50. PubMed ID: 11223673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the impact of CTMH guidelines on the management of benign prostatic hyperplasia].
    Lebdai S; Rahmène Azzouzi A; Delongchamps NB; Benchikh A; Campeggi A; Cornu JN; Dumonceau O; Faix A; Fourmarier M; Haillot O; Lukacs B; Mathieu R; Misrai V; Robert G; de La Taille A; Descazeaud A
    Prog Urol; 2015 Jan; 25(1):47-53. PubMed ID: 25453357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.